MT
Mamatha Thankam Jacob
About Mamatha Thankam Jacob
Data last updated:
Mamatha Thankam Jacob is a Director at Emerald Clinical Trials India Private Limited (since 2024). The company operates in Pharma. Emerald Clinical Trials India Private Limited reported revenue of ₹46.42 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Emerald Clinical Trials India Private Limited U73100KA2012FTC080639 | Director | 26 Sep 2024 | 2012 | ₹46.42 Cr (FY 2025) | Active |
Board colleagues of Mamatha Thankam Jacob
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anthony Stephen Proctor | 11324929 | Emerald Clinical Trials India Private Limited | Director |
| Ghosh Dwaipayan | 11151735 | Emerald Clinical Trials India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mamatha Thankam Jacob
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mamatha Thankam Jacob
Mamatha Thankam Jacob currently holds 1 directorship: Emerald Clinical Trials India Private Limited (Director, since 26 Sep 2024, revenue ₹46.42 Cr (FY 2025)).
Mamatha Thankam Jacob was first appointed on 26 Sep 2024 as Director at Emerald Clinical Trials India Private Limited.
The current boards of Mamatha Thankam Jacob's companies include Anthony Stephen Proctor (Emerald Clinical Trials India Private Limited), Ghosh Dwaipayan (Emerald Clinical Trials India Private Limited).